The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland

Allen M. Chen, Joaquin Garcia, M. Kara Bucci, Jeanne M. Quivey, David W. Eisele

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Purpose: To evaluate the impact of postoperative radiation therapy on the clinical course of patients with carcinoma ex pleomorphic adenoma of the parotid gland. Methods and Materials: Between 1960 and 2004, 63 patients were treated with definitive surgery for carcinoma ex pleomorphic adenoma of the parotid gland. Forty patients (63%) received postoperative radiation therapy to a median dose of 60 Gy (range, 45-71 Gy). Adenocarcinoma (29 patients), salivary duct carcinoma (16 patients), and adenoid cystic carcinoma (9 patients) were the most common malignant subtypes. Pathologic T -stage was: 16% T1, 33% T2, 32% T3, and 19% T4. Twenty-one patients (33%) had microscopically positive margins and 39 (62%) had perineural invasion. Median follow-up was 50 months (range, 2-96 months). Results: The use of postoperative therapy significantly improved 5-year local control from 49% to 75% (p = 0.005) and was associated with an improvement in survival among patients without evidence of cervical lymph node metastasis (p = 0.01). A Cox proportional hazard model identified pathologic involvement of cervical lymph nodes as an independent predictor of overall survival. Overall survival was 16% for patients with pathologic N-positive disease compared with 67% for those whose lymph node status was negative or unknown (p = 0.001). Conclusion: Surgery followed by postoperative radiation should be considered the standard of care for patients with carcinoma ex pleomorphic adenoma.

Original languageEnglish (US)
Pages (from-to)138-143
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume67
Issue number1
DOIs
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

salivary glands
Pleomorphic Adenoma
Parotid Gland
radiation therapy
Radiotherapy
cancer
Carcinoma
lymphatic system
Lymph Nodes
surgery
Survival
Salivary Ducts
Adenoid Cystic Carcinoma
metastasis
Standard of Care
ducts
Proportional Hazards Models
hazards
margins
therapy

Keywords

  • Carcinoma
  • Parotid gland
  • Pleomorphic adenoma
  • Radiation therapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. / Chen, Allen M.; Garcia, Joaquin; Bucci, M. Kara; Quivey, Jeanne M.; Eisele, David W.

In: International Journal of Radiation Oncology Biology Physics, Vol. 67, No. 1, 01.01.2007, p. 138-143.

Research output: Contribution to journalArticle

Chen, Allen M. ; Garcia, Joaquin ; Bucci, M. Kara ; Quivey, Jeanne M. ; Eisele, David W. / The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. In: International Journal of Radiation Oncology Biology Physics. 2007 ; Vol. 67, No. 1. pp. 138-143.
@article{8acc27f3e2d040678634f4ff54a0c953,
title = "The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland",
abstract = "Purpose: To evaluate the impact of postoperative radiation therapy on the clinical course of patients with carcinoma ex pleomorphic adenoma of the parotid gland. Methods and Materials: Between 1960 and 2004, 63 patients were treated with definitive surgery for carcinoma ex pleomorphic adenoma of the parotid gland. Forty patients (63{\%}) received postoperative radiation therapy to a median dose of 60 Gy (range, 45-71 Gy). Adenocarcinoma (29 patients), salivary duct carcinoma (16 patients), and adenoid cystic carcinoma (9 patients) were the most common malignant subtypes. Pathologic T -stage was: 16{\%} T1, 33{\%} T2, 32{\%} T3, and 19{\%} T4. Twenty-one patients (33{\%}) had microscopically positive margins and 39 (62{\%}) had perineural invasion. Median follow-up was 50 months (range, 2-96 months). Results: The use of postoperative therapy significantly improved 5-year local control from 49{\%} to 75{\%} (p = 0.005) and was associated with an improvement in survival among patients without evidence of cervical lymph node metastasis (p = 0.01). A Cox proportional hazard model identified pathologic involvement of cervical lymph nodes as an independent predictor of overall survival. Overall survival was 16{\%} for patients with pathologic N-positive disease compared with 67{\%} for those whose lymph node status was negative or unknown (p = 0.001). Conclusion: Surgery followed by postoperative radiation should be considered the standard of care for patients with carcinoma ex pleomorphic adenoma.",
keywords = "Carcinoma, Parotid gland, Pleomorphic adenoma, Radiation therapy",
author = "Chen, {Allen M.} and Joaquin Garcia and Bucci, {M. Kara} and Quivey, {Jeanne M.} and Eisele, {David W.}",
year = "2007",
month = "1",
day = "1",
doi = "10.1016/j.ijrobp.2006.07.1380",
language = "English (US)",
volume = "67",
pages = "138--143",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland

AU - Chen, Allen M.

AU - Garcia, Joaquin

AU - Bucci, M. Kara

AU - Quivey, Jeanne M.

AU - Eisele, David W.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Purpose: To evaluate the impact of postoperative radiation therapy on the clinical course of patients with carcinoma ex pleomorphic adenoma of the parotid gland. Methods and Materials: Between 1960 and 2004, 63 patients were treated with definitive surgery for carcinoma ex pleomorphic adenoma of the parotid gland. Forty patients (63%) received postoperative radiation therapy to a median dose of 60 Gy (range, 45-71 Gy). Adenocarcinoma (29 patients), salivary duct carcinoma (16 patients), and adenoid cystic carcinoma (9 patients) were the most common malignant subtypes. Pathologic T -stage was: 16% T1, 33% T2, 32% T3, and 19% T4. Twenty-one patients (33%) had microscopically positive margins and 39 (62%) had perineural invasion. Median follow-up was 50 months (range, 2-96 months). Results: The use of postoperative therapy significantly improved 5-year local control from 49% to 75% (p = 0.005) and was associated with an improvement in survival among patients without evidence of cervical lymph node metastasis (p = 0.01). A Cox proportional hazard model identified pathologic involvement of cervical lymph nodes as an independent predictor of overall survival. Overall survival was 16% for patients with pathologic N-positive disease compared with 67% for those whose lymph node status was negative or unknown (p = 0.001). Conclusion: Surgery followed by postoperative radiation should be considered the standard of care for patients with carcinoma ex pleomorphic adenoma.

AB - Purpose: To evaluate the impact of postoperative radiation therapy on the clinical course of patients with carcinoma ex pleomorphic adenoma of the parotid gland. Methods and Materials: Between 1960 and 2004, 63 patients were treated with definitive surgery for carcinoma ex pleomorphic adenoma of the parotid gland. Forty patients (63%) received postoperative radiation therapy to a median dose of 60 Gy (range, 45-71 Gy). Adenocarcinoma (29 patients), salivary duct carcinoma (16 patients), and adenoid cystic carcinoma (9 patients) were the most common malignant subtypes. Pathologic T -stage was: 16% T1, 33% T2, 32% T3, and 19% T4. Twenty-one patients (33%) had microscopically positive margins and 39 (62%) had perineural invasion. Median follow-up was 50 months (range, 2-96 months). Results: The use of postoperative therapy significantly improved 5-year local control from 49% to 75% (p = 0.005) and was associated with an improvement in survival among patients without evidence of cervical lymph node metastasis (p = 0.01). A Cox proportional hazard model identified pathologic involvement of cervical lymph nodes as an independent predictor of overall survival. Overall survival was 16% for patients with pathologic N-positive disease compared with 67% for those whose lymph node status was negative or unknown (p = 0.001). Conclusion: Surgery followed by postoperative radiation should be considered the standard of care for patients with carcinoma ex pleomorphic adenoma.

KW - Carcinoma

KW - Parotid gland

KW - Pleomorphic adenoma

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=33845625645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845625645&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2006.07.1380

DO - 10.1016/j.ijrobp.2006.07.1380

M3 - Article

C2 - 17049183

AN - SCOPUS:33845625645

VL - 67

SP - 138

EP - 143

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -